Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (161-170 of 366) with videos related to

Pageof 37
Sort By:
Breast Cancer Research and Treatment|March 25, 2025
Population attributable risk of a competing-risk model for breast cancer and non-breast cancer death among women ≥ 65 yearsMara A Schonberg, Emily A Wolfson, A Heather Eliassen, et al.
Journal of the American Geriatrics Society|May 31, 2017
Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health InitiativeRebecca L Drieling, Andrea Z LaCroix, Shirley A A Beresford, et al.
International Journal of Epidemiology|January 9, 2022
Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women's Health InitiativeRita Peila, Rowan T Chlebowski, Tarah J Ballinger, et al.
Journal of the National Cancer Institute|November 15, 2007
Predicting risk of breast cancer in postmenopausal women by hormone receptor statusRowan T Chlebowski, Garnet L Anderson, Dorothy S Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Estrogen plus progestin and colorectal cancer incidence and mortalityMichael S Simon, Rowan T Chlebowski, Jean Wactawski-Wende, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI)Jane A Cauley, Michelle E Danielson, Guru Rajesh Jammy, et al.
Archives of Internal Medicine|October 14, 2009
New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer riskCarolyn J Crandall, Aaron K Aragaki, Rowan T Chlebowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Oral bisphosphonate use and risk of postmenopausal endometrial cancerPolly A Newcomb, Michael N Passarelli, Amanda I Phipps, et al.
Archives of Internal Medicine|February 27, 2008
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsyRowan T Chlebowski, Garnet Anderson, Mary Pettinger, et al.
Journal of Medical Internet Research|April 10, 2020
Online Health Information-Seeking Among Older Women With Chronic Illness: Analysis of the Women's Health InitiativeMina S Sedrak, Enrique Soto-Perez-De-Celis, Rebecca A Nelson, et al.
Pageof 37

Showing results (161-170 of 366) with videos related to

Sort By:
Pageof 37
Breast Cancer Research and Treatment|March 25, 2025
Population attributable risk of a competing-risk model for breast cancer and non-breast cancer death among women ≥ 65 yearsMara A Schonberg, Emily A Wolfson, A Heather Eliassen, et al.
Journal of the American Geriatrics Society|May 31, 2017
Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health InitiativeRebecca L Drieling, Andrea Z LaCroix, Shirley A A Beresford, et al.
International Journal of Epidemiology|January 9, 2022
Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women's Health InitiativeRita Peila, Rowan T Chlebowski, Tarah J Ballinger, et al.
Journal of the National Cancer Institute|November 15, 2007
Predicting risk of breast cancer in postmenopausal women by hormone receptor statusRowan T Chlebowski, Garnet L Anderson, Dorothy S Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Estrogen plus progestin and colorectal cancer incidence and mortalityMichael S Simon, Rowan T Chlebowski, Jean Wactawski-Wende, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI)Jane A Cauley, Michelle E Danielson, Guru Rajesh Jammy, et al.
Archives of Internal Medicine|October 14, 2009
New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer riskCarolyn J Crandall, Aaron K Aragaki, Rowan T Chlebowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Oral bisphosphonate use and risk of postmenopausal endometrial cancerPolly A Newcomb, Michael N Passarelli, Amanda I Phipps, et al.
Archives of Internal Medicine|February 27, 2008
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsyRowan T Chlebowski, Garnet Anderson, Mary Pettinger, et al.
Journal of Medical Internet Research|April 10, 2020
Online Health Information-Seeking Among Older Women With Chronic Illness: Analysis of the Women's Health InitiativeMina S Sedrak, Enrique Soto-Perez-De-Celis, Rebecca A Nelson, et al.
Pageof 37